141 related articles for article (PubMed ID: 8151095)
1. Effects of vasopressin and nicardipine on hemodynamics and liver function in patients with cirrhosis: comparison with vasopressin alone.
Iwao T; Toyonaga A; Ikegami M; Oho K; Sumino M; Sakaki M; Shigemori H; Nakayama M; Sasaki E; Tanikawa K
J Hepatol; 1993 Nov; 19(3):345-52. PubMed ID: 8151095
[TBL] [Abstract][Full Text] [Related]
2. Nicardipine infusion improved hepatic function but failed to reduce hepatic venous pressure gradient in patients with cirrhosis.
Iwao T; Toyonaga A; Ikegami M; Sugawara H; Sumino M; Takagi K; Oho K; Sakaki M; Ohkubo K; Inoue R
Am J Gastroenterol; 1992 Mar; 87(3):326-31. PubMed ID: 1539567
[TBL] [Abstract][Full Text] [Related]
3. Nicardipine increases hepatic blood flow and the hepatic clearance of indocyanine green in patients with cirrhosis.
García-Pagán JC; Feu F; Luca A; Fernández M; Pizcueta P; Bosch J; Rodés J
J Hepatol; 1994 Jun; 20(6):792-6. PubMed ID: 7930480
[TBL] [Abstract][Full Text] [Related]
4. Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis.
García-Pagán JC; Escorsell A; Feu F; Bandi JC; Moitinho E; Casado M; Bosch J; Rodés J
J Hepatol; 1996 Apr; 24(4):430-5. PubMed ID: 8738729
[TBL] [Abstract][Full Text] [Related]
5. Portohepatic pressures, hepatic function, and blood gases in the combination of nitroglycerin and vasopressin: search for additive effects in cirrhotic portal hypertension.
Iwao T; Toyonaga A; Ikegami M; Sumino M; Oho K; Sakaki M; Nishizono M; Tanikawa K
Am J Gastroenterol; 1992 Jun; 87(6):719-24. PubMed ID: 1590307
[TBL] [Abstract][Full Text] [Related]
6. Effects of vaso-active agents on hepatic function and blood gases in patients with cirrhosis: a study of vasopressin and nitroglycerin.
Iwao T; Toyonaga A; Sumino M; Takagi K; Oho K; Ohkubo K; Inoue R; Tanikawa K
J Gastroenterol Hepatol; 1992; 7(2):148-53. PubMed ID: 1571496
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic effects of vasopressin, alone and in combination with nitroprusside, in patients with liver cirrhosis and portal hypertension.
Mols P; Hallemans R; Van Kuyk M; Melot C; Lejeune P; Ham H; Vertongen F; Naeije R
Ann Surg; 1984 Feb; 199(2):176-81. PubMed ID: 6696534
[TBL] [Abstract][Full Text] [Related]
8. Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function.
Navasa M; Chesta J; Bosch J; Rodés J
Gastroenterology; 1989 Apr; 96(4):1110-8. PubMed ID: 2925055
[TBL] [Abstract][Full Text] [Related]
9. Effects of vasopressin on portal hemodynamics in patients with portal hypertension.
Ohnishi K; Saito M; Nakayama T; Hatano H; Okuda K
Am J Gastroenterol; 1987 Feb; 82(2):135-8. PubMed ID: 2949601
[TBL] [Abstract][Full Text] [Related]
10. Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension.
Groszmann RJ; Kravetz D; Bosch J; Glickman M; Bruix J; Bredfeldt J; Conn HO; Rodes J; Storer EH
Hepatology; 1982; 2(6):757-62. PubMed ID: 6815044
[TBL] [Abstract][Full Text] [Related]
11. Vasopressin and vasopressin plus nitroglycerin for portal hypertension. Effects on systemic and splanchnic hemodynamics and coronary blood flow.
Rector WG; Hossack KF
J Hepatol; 1989 May; 8(3):308-15. PubMed ID: 2499616
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic effects of a combination of vasopressin and ketanserin in patients with hepatitis b-related cirrhosis.
Lee FY; Tsai YT; Lin HC; Lee SD; Hsia HC; Lin WJ; Wang SS; Lai KH; Lo KJ
J Hepatol; 1992 May; 15(1-2):54-8. PubMed ID: 1506656
[TBL] [Abstract][Full Text] [Related]
13. Vasopressin-induced changes in splanchnic blood flow and hepatic and portal venous pressures in liver resection.
Bown LS; Ricksten SE; Houltz E; Einarsson H; Söndergaard S; Rizell M; Lundin S
Acta Anaesthesiol Scand; 2016 May; 60(5):607-15. PubMed ID: 26763649
[TBL] [Abstract][Full Text] [Related]
14. [The effects of cimetidine on splanchnic hemodynamics in cirrhotic patients with portal hypertension].
Li S
Zhonghua Wai Ke Za Zhi; 1993 Apr; 31(4):207-9. PubMed ID: 8275833
[TBL] [Abstract][Full Text] [Related]
15. Reduction of portal pressure by chronic administration of isosorbide dinitrate in patients with cirrhosis: effects on systemic and splanchnic hemodynamics and liver function.
Ikegami M; Toyonaga A; Tanikawa K
Am J Gastroenterol; 1992 Sep; 87(9):1160-4. PubMed ID: 1519573
[TBL] [Abstract][Full Text] [Related]
16. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
Bosch J; Kravetz D; Rodes J
Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
[TBL] [Abstract][Full Text] [Related]
17. Treatment of portal hypertension with isosorbide dinitrate alone and in combination with vasopressin.
Hallemans R; Naeije R; Mols P; Mélot C; Reding P
Crit Care Med; 1983 Jul; 11(7):536-40. PubMed ID: 6861502
[TBL] [Abstract][Full Text] [Related]
18. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.
García-Pagán JC; Feu F; Bosch J; Rodés J
Ann Intern Med; 1991 May; 114(10):869-73. PubMed ID: 2014947
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis.
Lee WC; Lin HC; Yang YY; Hou MC; Lee FY; Chang FY; Lee SD
Am J Gastroenterol; 2001 Apr; 96(4):1210-6. PubMed ID: 11316172
[TBL] [Abstract][Full Text] [Related]
20. Effects of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertension.
Navasa M; Bosch J; Reichen J; Bru C; Mastai R; Zysset T; Silva G; Chesta J; Rodés J
Hepatology; 1988; 8(4):850-4. PubMed ID: 3391511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
